Every 23 seconds, someone in America is diagnosed with diabetes, a stark reminder of the growing need for effective diabetes management solutions. For individuals facing this diagnosis, understanding and accessing resources is crucial. Sherri Shepherd’s personal experience highlights this urgency. Concerned about her health after her son’s poignant question, she sought better ways to manage her diabetes. Her journey underscores the importance of tools like continuous glucose monitoring (CGM) and the significance of patient assistance programs that make these technologies accessible. Abbott Diabetes Care is at the forefront of this effort, offering innovative solutions and support to empower individuals in their diabetes management journey.
Continuous Glucose Monitoring (CGM) systems, such as Abbott’s FreeStyle Libre, represent a significant advancement in diabetes care. Instead of relying on fingersticks, CGM provides real-time glucose readings, empowering users with the knowledge to make informed decisions throughout the day. This constant stream of data helps individuals proactively manage their glucose levels, preventing dangerous spikes and mitigating the long-term risks associated with diabetes complications. As Sherri Shepherd discovered, CGM provides the insights needed to take control and live a healthier life.
Despite the proven benefits of CGM, only a fraction of people with diabetes worldwide are utilizing this life-changing technology. Abbott Diabetes Care recognizes this gap and is actively working to increase CGM adoption through various initiatives, including patient assistance programs and awareness campaigns. Their commitment extends beyond just providing technology; they aim to ensure that individuals have access to the tools and support necessary to effectively manage their condition.
One key aspect of Abbott’s patient assistance efforts is initiatives like the FreeStyle Libre free trial program. This program allows eligible individuals to experience the benefits of CGM firsthand for two weeks, removing a significant barrier to entry – the initial cost and uncertainty. By trying CGM without financial commitment, patients can understand how it works and assess its impact on their daily lives before making a purchase decision. This trial program acts as a crucial stepping stone, enabling more people to access and benefit from CGM technology.
Furthermore, Abbott Diabetes Care demonstrates its dedication to diabetes awareness and support through campaigns like the “Countdown at a Crossroads” initiative. In collaboration with the American Diabetes Association, Abbott pledged to donate 99 cents for every visit to their campaign webpage, raising up to $100,000 for diabetes awareness and education. This initiative not only generates crucial funds for diabetes support but also highlights the importance of CGM technology in managing the condition effectively.
The FreeStyle Libre 3 system, Abbott’s latest innovation, exemplifies their commitment to advancing CGM technology. As the most accurate 14-day CGM, it provides minute-by-minute glucose readings directly to a smartphone, all within a discreet and user-friendly design. Its small size, comparable to two stacked pennies, and ease of use make CGM accessible and convenient for a wide range of individuals, including pregnant women and children as young as four years old.
Abbott’s MyFreeStyle program further complements their patient assistance efforts by offering diabetes education and ongoing support. This comprehensive program provides resources and guidance to help individuals understand their diabetes and effectively utilize CGM technology as part of their management plan. By combining technology with education and support, Abbott empowers individuals to take a proactive role in their health and well-being.
In conclusion, Abbott Diabetes Care is making significant strides in improving diabetes management through its innovative CGM technology and patient-centric approach. The FreeStyle Libre system, coupled with patient assistance initiatives like the free trial program and awareness campaigns, are increasing access to this life-changing technology. By focusing on both technological advancements and patient support, Abbott is empowering individuals to navigate their diabetes journey with greater confidence and control, paving the way for a healthier future for millions affected by diabetes.
